[A preliminary study of surgical therapy and combined therapy for cervical esophageal carcinoma].
52 patients with carcinoma of cervical esophagus were treated surgically. Their 3- and 5-year survival rate of was 38.5% and 35.1% respectively. The 3- and 5-year survival rate for surgery alone was 15.4% (2/13) and 9.1% (1/11). The 3- and 5-year survival rate for combined therapy (pre- or postoperative radiation and surgery) was 48.1% (13/27) and 52.9% (9/17). The 3- and 5-year survival rate for surgical salvage after failure of radical radiotherapy was 41.7% (5/12) and 33.3% (3/9). Our data suggest that the result of combined therapy is much better than the result of surgery or radiotherapy. The invation of recurrent nerve, hypopharynx, trachea, larynx and thyroid gland by tumor is contracindicated to surgery.
Qi
Y
Y
Cancer Hospital Chinese, Academy of Medical Sciences, Beijing.
Tu
G
G
Tang
P
P
D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate